The collaboration will make use of Fluidigm's automated microfluidic systems to accelerate the design of panels for translational and clinical researchers.
The two companies hope to provide translational researchers a faster, more comprehensive option for the design and validation of Accel-Amplicon panels.
The companies will offer CDI's human induced pluripotent stem cell-derived tissue cells with Nanion's ion channel drug discovery and screening platform.
The firms will comarket AATI's automated CE systems for quality control analysis of nucleic acids in Illumina's next-generation sequencing workflows.
The companies will market Angle's Parsortix system for harvesting circulating tumor cells with Qiagen's liquid biopsy product portfolio.
The companies will market Agena's MassArray Dx system with HeartGenetics' HeartDecode genetic testing software and cardiovascular assays.
Separately, FlowJo and Cytapex Bioinformatics said they have partnered to provide bioinformatics consulting and services for flow cytometry data analysis.
The companies will develop a portfolio of indexed adapters specifically designed for multiplex NGS and optimized for use on Illumina systems such as the NovaSeq.
The companies will market Proteos' protein production services alongside Protea's bioanalytical services.
The agreement combines TTP's Mosquito with AATI's Fragment Analyzer to improve library preparation for next-generation sequencing.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.